Market Cap 6.19B
Revenue (ttm) 1.90B
Net Income (ttm) 235.24M
EPS (ttm) N/A
PE Ratio 29.14
Forward PE 7.41
Profit Margin 12.37%
Debt to Equity Ratio 0.74
Volume 3,799,300
Avg Vol 1,538,428
Day's Range N/A - N/A
Shares Out 97.03M
Stochastic %K 2%
Beta 0.79
Analysts Strong Sell
Price Target $171.52

Latest News on SRPT

Sarepta: Should Investors Run For The Exit?

Mar 20, 2025, 1:55 PM EDT - 13 days ago

Sarepta: Should Investors Run For The Exit?


Sarepta says patient dies after treatment with gene therapy

Mar 18, 2025, 8:17 AM EDT - 15 days ago

Sarepta says patient dies after treatment with gene therapy


Sarepta Therapeutics: Guidance Suggests A Year Of Upside Likely

Jan 16, 2025, 1:23 PM EST - 2 months ago

Sarepta Therapeutics: Guidance Suggests A Year Of Upside Likely


Hansa Biopharma to attend 2025 J.P. Morgan Healthcare Conference

Jan 7, 2025, 11:19 AM EST - 3 months ago

Hansa Biopharma to attend 2025 J.P. Morgan Healthcare Conference


Sarepta Therapeutics Muscles Up In DMD Race

Sep 18, 2024, 11:59 PM EDT - 7 months ago

Sarepta Therapeutics Muscles Up In DMD Race


Biotech Stock Flashing Bull Signal

Aug 14, 2024, 2:39 PM EDT - 8 months ago

Biotech Stock Flashing Bull Signal